This bill proposes to amend current statutes by allowing assisted living homes and centers to offer mild hyperbaric oxygen therapy (HBOT) to residents. The new provisions specify that this therapy must be administered through a Class II mild hyperbaric oxygen chamber registered with the FDA, and it must be prescribed by a physician. Additionally, the bill mandates that a trained staff member must be present whenever a resident receives HBOT, and it requires facilities to provide residents with information regarding the therapy's risks and contraindications.

Furthermore, the bill introduces specific restrictions on the administration of HBOT to residents requiring directed care services, ensuring that such therapy is only provided with a physician's order and informed consent from the resident or their representative. The Department of Health Services is also granted the authority to adopt necessary rules related to the implementation of these provisions. Overall, the bill updates the current law to incorporate these new guidelines and requirements for the safe use of mild HBOT in assisted living facilities.

Statutes affected:
Introduced Version: 36-420.06
Senate Engrossed Version: 36-420.06